Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Dollar Edges Higher; Sterling Under Brexit Pressure

Published 12/08/2020, 02:56 AM
Updated 12/08/2020, 02:58 AM
© Reuters.

By Peter Nurse

Investing.com - The dollar edged higher from weak levels in early European trade Tuesday, with traders balancing rising Covid-19 cases and expanding lockdowns with likely fiscal stimulus and a vaccine rollout.

At 3:55 AM ET (0755 GMT), the Dollar Index, which tracks the greenback against a basket of six other currencies, was up 0.1% at 90.907, only slightly above the 2 1/2-year low of 90.471 on Friday.

EUR/USD edged 0.1% higher to 1.2112, but off Friday’s high of 1.2177, a level last seen in April 2018, while the risk-sensitive AUD/USD was down 0.2% at 0.7409.

The U.S. Congress is poised to vote this week on a stopgap funding measure. This is likely to pass, allowing the lawmakers more time to negotiate an emergency coronavirus stimulus plan, with a deal of around $908 billion already on the table.

The need for such a package is beyond dispute, with many states posting new records for deaths and hospitalizations following the Thanksgiving holiday. This has prompted new restrictions, with California shutting all but critical infrastructure and retail operations in its worst-hit areas, while a ban on indoor restaurant dining is also looming in New York City.

That said, ING kept its bearish dollar call, expecting the greenback to fall a further 5%-10% against most currencies in 2021.

“Central to this bearish dollar call is: (i) continued good news on vaccine approvals and roll outs such that economic growth can accelerate (probably from 2Q onwards) and (ii) the Fed keeping the punchbowl of cheap liquidity in place and not blinking when inflation starts to rise,” ING analysts wrote in a research note.

The U.K. starts to vaccinate its public Tuesday with the Pfizer/BioNTech injection, while the U.S. Food and Drug Administration meets to potentially authorize the use of this vaccine on Thursday. 

Elsewhere, GBP/USD dropped 0.3% to 1.3336, continuing to retreat from the two-and-a-half year high of $1.3540 seen on Friday, amid uncertainty over the outcome of a post-Brexit trade deal.

UK Prime Minister Boris Johnson is set to travel to Brussels later Tuesday in a last-ditch effort to broker a deal with European Commission President Ursula von der Leyen, as difficulties remain over issues such as fishing rights waters around the UK, fair competition and ways to solve future disputes.

The relatively small losses in sterling suggest that most traders still expect a deal to be agreed at the last minute, but time is running short.

“A deal would unlock some modest upside for sterling, but a lack of risk premium means there is potential for plenty more downside should talks end without an agreement,” ING analysts said.

 

Latest comments

https://www.nbcnews.com/news/world/britain-becomes-first-roll-out-clinically-approved-biontech-pfizer-vaccine-n1250330
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.